Document:

Exhibit 10.1
October 26, 2021
 
James Watkins
15345 Barranca Parkway
Irvine, CA 92618
RE:  Employment Agreement
 
Dear Jim:
 
This letter agreement (this “Agreement”) shall confirm the terms of your continued employment with Boot Barn, Inc. (the “Company”), effective as of November 1, 2021 (“Effective Date”).
 
Position/Duties:  You agree to serve the Company as its Chief Financial Officer and Secretary, reporting to the President and Chief Executive Officer (“CEO”). You will have such duties consistent with your position and as assigned to you from time to time by the Company. You will perform your duties at the Company’s corporate offices in Orange County, California, subject to customary travel as reasonably required.  You also shall serve as the Chief Financial Officer and Secretary of Boot Barn Holdings, Inc. and may be asked to perform duties and services for certain of the Company’s affiliated entities, without additional compensation.  You agree to devote your full business time attention and energies to, and perform faithfully, professionally and to the best of your ability, the duties and responsibilities of your position.
 
Term:  This Agreement shall commence on the Effective Date and continue until the first anniversary of the Effective Date, unless earlier terminated as set forth herein, provided, however, that commencing on the first anniversary of the Effective Date and on each anniversary date thereafter, this Agreement shall be automatically renewed for an additional one-year period unless, at least sixty (60) calendar days prior to such date, the Company or you provide the other party written notice that such party does not wish to renew the term.
 
Base Salary:  You will receive an annualized salary of $375,000.00, less applicable deductions, payable in accordance with the Company’s regular payroll practices.
 
Bonuses:  You will be eligible to participate in the Company’s key bonus plan pursuant to the terms, financial targets and performance goals established by the Compensation Committee (“Compensation Committee”) of the Board of Directors of Boot Barn Holdings, Inc., from time to time.   If the Company achieves its budget and you achieve certain performance objectives, each as established by the Compensation Committee and the Company, you will be eligible to earn a target bonus of 60% of your base salary with an opportunity to receive a maximum aggregate bonus of up to 120% of your base salary if the Company achieves additional performance targets and you achieve certain performance objectives, each as established by the Compensation Committee and the Company, payable within one hundred twenty (120) days after the end of the Company’s fiscal year ending March 31st, provided that, except as otherwise set forth in this Agreement, you are employed in good standing on the bonus payment date.  With respect to the 2022 fiscal year, the target bonus and maximum bonus opportunities described in the preceding sentence shall be pro-rated for the portion of such fiscal year that elapses upon and following the Effective Date, and your current target bonus and maximum bonus opportunities shall apply for the portion of the fiscal year that elapses prior to the Effective Date. 
 
Benefits:  You will accrue five (5) weeks of paid time off each year, with a maximum paid time off cap of seven and one-half (7.5) weeks in accordance with the Company’s paid time off policy.  You will be eligible to receive seven (7) paid holidays each year.  You also will be eligible to participate in the Company’s benefit plans and programs.  The eligibility requirements and other terms and conditions of any Company benefits shall be governed by the Company’s applicable benefit policy and plan documents, as in effect and amended from time to time.  The Company reserves the right to modify, reduce or eliminate any Company benefits at any time, in its discretion.
 
Expenses:  The Company shall reimburse you for all reasonable business expenses of types authorized by the Company and reasonably and necessarily incurred by you in the performance of your duties hereunder, in accordance with the Company’s reimbursement policies, provided that, you must submit proof of such business 

​

expenses and comply with such reasonable budget limitations and approval and reporting requirements with respect to expenses as the Company may establish from time to time. 
 
Employment Policies and Confidential Information:  You agree to comply with the Company’s standard policies and work rules, including as set forth in the Employee Handbook, as amended from time to time.  The Company’s Confidential and Proprietary Information Agreement (“Confidential Information Agreement”) previously executed by you shall continue in full force and effect.
 
Arbitration:  You agree that all claims arising out of or relating to your employment with the Company, including claims arising out of this Agreement, the enforceability of this arbitration provision or in connection with your separation from the Company, shall be resolved by binding arbitration in Orange County, California pursuant to the Federal Arbitration Act (“Covered Claims”).  This agreement to arbitrate does not prohibit either party from filing an application for a provisional remedy to prevent actual or threatened irreparable harm in accordance with California law.  The dispute will be arbitrated in accordance with the rules of the American Arbitration Association (“AAA”) under the Employment Arbitration Rules and Mediation Procedures which may be found at https://www.adr.org/sites/default/files/EmploymentRules_Web_2.pdf.  A hard copy of the AAA rules will be provided to you upon your request. The Company shall pay all expenses peculiar to arbitration including the arbitration administrative costs and the arbitrator’s fees in accordance with California law and the AAA rules.  Each party shall bear his/its own attorneys’ fees and legal costs.  However, if any party prevails on a statutory claim which affords the prevailing party attorneys’ fees and/or legal costs, the arbitrator may award such reasonable attorneys’ fees and/or legal costs to the prevailing party consistent with applicable law.  This agreement to arbitrate does not apply to: (i) claims for workers’ compensation, disability benefits or unemployment compensation benefits; (ii) administrative claims before the United States Equal Employment Opportunity Commission, the Department of Fair Employment and Housing, or the California Division of Labor Standards Enforcement (DLSE); (iii) PAGA claims (Private Attorneys General Act); (iv) claims based on any pension or welfare plan or collective bargaining agreement, the terms of which may contain arbitration or other non-judicial dispute resolution procedure; (v) any unfair labor practice charge which is to be brought under the National Labor Relations Act; (vi) claims for public injunctive relief; or (vii) any claims that are not subject to mandatory arbitration by law. YOU UNDERSTAND AND AGREE THAT YOU ARE HEREBY WAIVING YOUR RIGHTS TO BRING ALL COVERED CLAIMS TO COURT INCLUDING THE RIGHT TO A JURY TRIAL.
 
Termination:  Your employment may terminate at any time during the term for the following reasons: (i) the Company may terminate you for Cause (defined herein) or without Cause, (ii) you may resign your employment with Good Reason (defined herein) or without Good Reason, (iii) either party may give notice of non-renewal as set forth above, or (iv) due to your death or Disability (defined herein).  If your employment is terminated for any reason, you shall receive: (A) your base salary through the termination date, (B) accrued but unused vacation through the termination date, (C) vested and nonforfeitable benefits pursuant to the terms of a Company benefit plan (other than a severance benefit plan or policy), and (D) reimbursement of expenses you have incurred up through the date of termination (the “Accrued Amounts”).
 
In the event your employment is terminated by the Company without Cause, by you for Good Reason or in the event the Company provides notice of non-renewal as set forth above, then in addition to the Accrued Amounts, the Company will pay you, at the time set forth below, the Severance Payment and the Bonus Payment, each as defined herein, provided that you timely sign and do not revoke (if applicable) a general release of all claims against the Company and its parents, affiliates and subsidiaries in a form provided to you by the Company (the “Release”) within sixty (60) days following the termination date. 
 
You shall not be entitled to the Severance Payment or Bonus Payment, or any other severance, bonus or other post-termination benefits (other than the Accrued Amounts) if the Company terminates your employment for Cause, you resign for any reason that does not constitute Good Reason, or your employment terminates due to death, Disability, due to you providing notice of non-renewal as set forth above or if you do not sign and/or you revoke the Release (in connection with the termination events described in the foregoing paragraph).  Upon the separation of your employment, however caused, (i) your position(s) as a director or officer of any parent, affiliate or subsidiary of the Company, including Boot Barn Holdings, Inc., shall automatically terminate and (ii) you must continue to comply with your post-termination obligations set forth in the Confidential Information Agreement.
 

​

Definitions:
 
“Bonus Payment” as used herein shall mean a prorated bonus for the year of your termination of employment, based on the bonus you would have been paid for the fiscal year to which the bonus relates had you remained employed on the bonus payment date, and calculated by multiplying the bonus by a fraction, the numerator of which is the number of days in the fiscal year which you were employed and the denominator of which is 365, payable within one hundred twenty (120) days after the end of the Company’s fiscal year ending March 31st as set forth above, and provided that the Release is irrevocable as of such payment date.
 
“Cause” as used herein shall mean: (i) your refusal or failure to substantially perform the duties of your position or follow the reasonable instructions of the Company or the Board of Directors of the Company (the “Board”); (ii) your failure to comply in any material respect with any written policies or procedures of the Company or the Board (including, but not limited to, the Company’s drug or anti-harassment policies, etc.); (iii) your engagement in any act of theft, fraud, embezzlement, willful misfeasance or misconduct, falsification of Company documents, misappropriation of funds or other assets of the Company, or committing any act which is materially damaging to the goodwill, business or reputation of the Company; (iv) your conviction or pleading guilty or nolo contendere to any felony or crime involving moral turpitude; or (v) your material breach of any of your obligations to the Company or the Confidential Information Agreement.
 
“Disability” as used herein shall mean your inability due to mental or physical incapacity to perform the essential functions of your job duties, with or without reasonable accommodation, for ninety (90) consecutive days or one hundred twenty (120) non-consecutive days in any twelve (12) month period, as determined by the Company.
 
“Good Reason” as used herein shall mean the occurrence of any of the following events without your consent: (i) any material diminution in your base salary, other than a diminution that was in conjunction with a salary reduction program for similarly-situated employees of the Company or its affiliates; (ii) any material and continuing diminution in your authority or responsibilities; (iii) changing the geographic location at which you provide services to the Company to a location more than thirty-five (35) miles from the then existing location and further from your residence; or (iv) requiring you to report to someone other than the CEO, provided however, that your resignation for Good Reason will be effective only if you provide written notice to the Company of any event constituting Good Reason within sixty (60) days after you become aware such event, and the Company does not cure such event within thirty (30) days after receipt of the notice, and provided further that, you terminate your employment within ninety (90) days of the date of your written notice.
 
“Severance Payment” as used herein shall mean your base salary in effect on the termination date, less applicable deductions, payable for a period of twelve (12) months from the termination date, as salary continuation payments in accordance with the Company’s normal payroll practices, the first installment of which shall be paid to you on the first regular payroll period following the sixtieth (60th) after the termination date (and will include any severance installment that would have otherwise been paid during the period following the termination date through the date of the first installment); provided that, the Release is irrevocable as of such date.
 
Notices:  All notices, requests, demands, claims, consents and other communications which are required, permitted or otherwise delivered hereunder shall in every case be in writing and shall be deemed properly served if: (a) delivered personally, (b) sent by registered or certified mail, in all such cases with first class postage prepaid, return receipt requested, or (c) delivered by a recognized overnight courier service, to the parties at the addresses as set forth below:
If to the Company: 15345 Barranca Parkway
   Irvine, CA 92618
   Attention: CEO
​
If to you:  At your residence address as maintained by the Company in the regular course of its business for payroll.
​

​

or to such other address as shall be furnished in writing by either party to the other party; provided that such notice or change in address shall be effective only when actually received by the other party.  Date of service of any such notices or other communications shall be: (a) the date such notice is personally delivered, (b) three days after the date of mailing if sent by certified or registered mail, or (c) one business day after date of delivery to the overnight courier if sent by overnight courier.
​
Successors and Assigns:  This Agreement shall not be assignable by you, provided however, your rights to payments hereunder shall, upon your death or incapacity, inure to the benefit of your personal or legal representatives, executors, administrators, heirs, devisees and legatees.  This Agreement will be binding upon and inure to the benefit of the Company, its successors and assigns, and may be assigned by the Company to any parent, subsidiary or affiliate thereof, or to a person or entity which is a successor in interest to substantially all of the business operations or assets of the Company.
 
Entire Agreement:  You confirm that no promises or statements that are contrary to the terms of this Agreement have been made to you by any Company representative.  This Agreement (along with the agreements referenced herein, including the Confidential Information Agreement) contains the parties’ complete agreement regarding the terms and conditions of your employment with the Company and supersedes all prior and contemporaneous agreements, negotiations and term sheets relating to the subject matter herein.  This Agreement can only be modified in writing signed by you and the CEO.
​
Withholding Taxes:  All amounts payable hereunder shall be subject to the withholding of all applicable taxes and deductions required by any applicable law.
 
409A:
 
Compliance.  It is intended that the compensation paid or delivered pursuant to this Agreement is either paid in compliance with, or is exempt from, Section 409A of the Internal Revenue Code, and the regulations promulgated thereunder (together, “Section 409A”), and this Agreement shall be interpreted and administered accordingly.  However, the Company does not warrant that all amounts paid or delivered hereunder will be exempt from, or paid in compliance with, Section 409A.  You agree to bear the risk of any adverse federal, state or local tax consequences and penalty taxes which may result from payments made in accordance with the terms of this Agreement, and you will not seek indemnification from the Company for any such tax consequences or penalties.  You acknowledge that you have been advised to seek the advice of a tax advisor with respect to the tax consequences of all such payments, including any adverse tax consequence under Section 409A and applicable state tax law.
 
Amounts Payable On Account of Termination.  If and to the extent necessary to comply with Section 409A, for the purposes of determining when amounts otherwise payable on account of your termination of employment under this Agreement will be paid, “terminate,” “terminated” or “termination” or words of similar import relating to your employment with the Company, as used in this Agreement, shall be construed as the date that you first incur a “separation from service” within the meaning of Section 409A.  Notwithstanding anything to the contrary herein, if you are deemed on the date of termination to be a “specified employee” of the Company, within the meaning of that term under Section 409A(a)(2)(B), then with regard to any payment or provision of any benefit that is considered nonqualified deferred compensation under Section 409A payable on account of a “separation of service,” such payment or benefit shall not be made or provided until the date which is the earlier of (i) the expiration of the six (6) month period measured from the date of your “separation of service” from the Company and (ii) the date of your death, to the extent required under Section 409A.  Upon the expiration of the foregoing delay period, all payments and benefits delayed pursuant to the previous sentence (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to you in a lump sum, without interest, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein.  In no event may you, directly or indirectly, designate the fiscal year of a payment.  
 
Interpretative Rules.  In applying Section 409A to amounts paid pursuant to this Agreement, any right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments.
 

​

Taxable Reimbursements.  Any taxable reimbursement of business or other expenses provided for under this Agreement shall be subject to the following conditions: (i) the expenses eligible for reimbursement in one taxable year shall not affect the expenses eligible for reimbursement in any other taxable year, (ii) the reimbursement of an eligible expense shall be made no later than the end of the year after the year in which such expense was incurred, and (iii) the right to reimbursement shall not be subject to liquidation or exchange for another benefit.  
​
Governing Law: This Agreement and the legal relations thus created between the parties hereto shall be governed by, and construed in accordance with, the internal laws of the State of California, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of California or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the State of California.  The parties hereto acknowledge and agree that this Agreement was executed and delivered in the State of California.
​
 
If the terms of this Agreement are acceptable to you, please sign below and return a copy to me. On behalf of the Company, we look forward to continuing working with you.
 
	 
	Regards,

	 
	 /s/ James G. Conroy

	 
	
	 
	James G. Conroy

	 
	President and Chief Executive Officer

 
 
AGREED AND ACCEPTED:
 
 
	/s/ James Watkins
	 
	Date:
	 October 26, 2021

	James Watkins
​
	 
	 

​

​Exhibit
4.1

 

UNLESS
PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND OF ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE
SECURITY BEFORE February 28, 2022.

 

THIS
WARRANT HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY
NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY.

 

The
number of common shares issuable upon exercise of this warrant may be less than the amounts set forth on the face hereof.

 

This
Warrant is issued pursuant to that certain Securities Purchase Agreement dated October 26, 2021 by and between the Company and the Holder
(as defined below) (the “Purchase Agreement”). Capitalized terms used and not otherwise defined herein shall have
the meanings set forth for such terms in the Purchase Agreement. Receipt of this Warrant by the Holder shall constitute acceptance and
agreement to all of the terms contained herein.

 

No. 10-27-2021-WarrantL1

 

siyata
mobile inc.

 

FORM
OF COMMON SHARES PURCHASE WARRANT

 

Siyata
Mobile Inc., a British Columbia corporation (together with any corporation which shall succeed to or assume the obligations of Siyata
Mobile Inc. hereunder, the “Company”), hereby certifies that, for value received, Lind Global Fund II LP, a Delaware
limited partnership (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company
at any time during the Exercise Period (as defined in Section 9) up to Two Million One Hundred Forty Two Thousand Eight Hundred
Fifty Seven (2,142,857) fully paid and non-assessable Common Shares (as defined in Section 9), at a purchase price per share
equal to the Exercise Price (as defined in Section 9). The number of Common Shares for which this Common Shares Purchase Warrant
(this “Warrant”) is exercisable and the Exercise Price are subject to adjustment as provided herein.

 

1.
DEFINITIONS. Certain terms are used in this Warrant as specifically defined in Section 9.

 

2.
EXERCISE OF WARRANT.

 

2.1.
Exercise. This Warrant may be exercised prior to its expiration pursuant to Section 2.5 hereof by the Holder at any time
or from time to time during the Exercise Period, by submitting the form of subscription attached hereto (the “Exercise Notice”)
duly executed by the Holder, to the Company at its principal office, indicating whether the Holder is electing to purchase a specified
number of shares by paying the Aggregate Exercise Price as provided in Section 2.2 or is electing to exercise this Warrant as
to a specified number of shares pursuant to the net exercise provisions of Section 2.3. On or before the first Trading Day following
the date on which the Company has received the Exercise Notice, the Company shall transmit by electronic mail an acknowledgement of confirmation
of receipt of the Exercise Notice. Subject to Section 2.4, this Warrant shall be deemed exercised for all purposes as of the close
of business on the day on which the Holder has delivered the Exercise Notice to the Company. The Aggregate Exercise Price, if any, shall
be paid by wire transfer to the Company within five (5) Business Days of the date of exercise and prior to the time the Company issues
the certificates evidencing the shares issuable upon such exercise. In the event this Warrant is not exercised in full, the Company may,
at its expense, require the Holder, after such partial exercise, to promptly return this Warrant to the Company and the Company will
forthwith issue and deliver to or upon the order of the Holder a new Warrant or Warrants of like tenor, in the name of the Holder or
as the Holder (upon payment by the Holder of any applicable transfer taxes) may request, calling in the aggregate on the face or faces
thereof for the number of Common Shares equal (without giving effect to any adjustment therein) to the number of such shares called for
on the face of this Warrant minus the number of such shares (without giving effect to any adjustment therein) for which this Warrant
shall have been exercised.

 

    

    

    

 

2.2.
Payment of Exercise Price by Wire Transfer. If the Holder elects to purchase a specified number of shares by paying the Aggregate
Exercise Price, the Holder shall pay such amount by wire transfer of immediately available funds to the account designated by the Company
in its acknowledgement of receipt of such Exercise Notice pursuant to Section 2.1.

 

2.3.
Net Exercise. If a registration statement covering the Common Shares that are the subject of the Notice of Exercise (the “Unavailable
Warrant Shares”) is not available for the resale of such Unavailable Warrant Shares to the public or upon exercise of this
Warrant in connection with a Fundamental Transaction, the Holder may elect to exercise this Warrant by receiving Common Shares equal
to the number of shares determined pursuant to the following formula:

 

X
= Y (A - B)

A

where,

 

		X =	the number
                                            of Common Shares to be issued to Holder;

 

		Y =	the number
                                            of Common Shares as to which this Warrant is to be exercised (as indicated on the Exercise
                                            Notice);

 

		A =	VWAP for
                                            the Trading Day immediately preceding the date of exercise; and

 

		B =	the Exercise
                                            Price.

 

2.4.
Antitrust Notification. If the Holder determines, in its sole judgment upon the advice of counsel, that the issuance of any Warrant
Shares pursuant to the terms hereof would be subject to the provisions of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (the “HSR Act”), the Company shall file as soon as practicable after the date on which the Company receives
notice from the Holder of the applicability of the HSR Act and a request to so file with the United States Federal Trade Commission and
the United States Department of Justice the notification and report form required to be filed by it pursuant to the HSR Act in connection
with such issuance.

 

2.5.
Termination. This Warrant shall terminate upon the earlier to occur of (i) exercise in full or (ii) the expiration of the Exercise
Period.

 

3.
REGISTRATION RIGHTS. The Holder of this Warrant has certain rights to require the Company to register its resale of the Warrant
Shares under the Securities Act and any blue sky or securities laws of any jurisdictions within the United States at the time and in
the manner specified in the Purchase Agreement.

 

    -2-

    

    

 

4.
DELIVERY OF STOCK CERTIFICATES ON EXERCISE.

 

4.1.
Delivery of Exercise Shares. As soon as practicable after any exercise of this Warrant and in any event within one (1) Trading
Days thereafter (such date, the “Exercise Share Delivery Date”), the Company shall, at its expense (including the
payment by it of any applicable issue or stamp taxes), cause to be issued in the name of and delivered to the Holder, or as the Holder
may direct, a certificate or certificates evidencing the number of fully paid and non-assessable Common Shares (which number shall be
rounded down to the nearest whole share in the event any fractional share may otherwise be issuable upon such exercise and the Company
shall pay a cash adjustment to the Holder in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise
Price) to which the Holder shall be entitled on such exercise, in such denominations as may be requested by the Holder, which certificate
or certificates shall be free of restrictive and trading legends (except for any such legends as may be required under the Securities
Act or during the Canadian Lock-Up Period pursuant to applicable Canadian Securities Laws). After the Canadian Lock-Up Period, in lieu
of delivering physical certificates for the Common Shares issuable upon any exercise of this Warrant, provided the Warrant Shares are
not restricted securities and the Company’s transfer agent is participating in the Depository Trust Company (“DTC”)
Fast Automated Securities Transfer program or a similar program, upon request of the Holder, the Company shall cause its transfer agent
to electronically transmit such Common Shares issuable upon exercise of this Warrant to the Holder (or its designee), by crediting the
account of the Holder’s (or such designee’s) broker with DTC through its Deposit Withdrawal Agent Commission system (provided
that the same time periods herein as for stock certificates shall apply) as instructed by the Holder (or its designee).

 

4.2.
Compensation for Buy-In on Failure to Timely Deliver Exercise Shares. In addition to any other rights available to the Holder,
if the Company fails to cause its transfer agent to transmit to the Holder Exercise Shares pursuant to an exercise on or before the Exercise
Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise)
or the Holder’s brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the Holder of the Exercise
Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (a) pay in cash
to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for
the Common Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Exercise Shares that the Company was
required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to
such purchase obligation was executed, and (b) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Exercise Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver
to the Holder the number of Common Shares that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Common Shares having a total purchase price of $11,000 to cover a Buy-In
with respect to an attempted exercise of Common Shares with an aggregate sale price giving rise to such purchase obligation of $10,000,
under clause (a) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide
the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and evidence of the amount of such loss.
Nothing herein shall limit a Holder’s right to pursue a decree of specific performance and/or injunctive relief with respect to
the Company’s failure to timely deliver Common Shares upon exercise of the Warrant as required pursuant to the terms hereof.

 

    -3-

    

    

 

4.3.
Charges, Taxes and Expenses. Issuance of Exercise Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Exercise Shares, all of which taxes and expenses shall be paid by
the Company, and such Exercise Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,
that in the event Exercise Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise
shall be accompanied by the Assignment Form attached hereto (the “Assignment Form”) duly executed by the Holder and
the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.

 

5.
CERTAIN ADJUSTMENT.

 

5.1.
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (a) pays a stock dividend or otherwise
makes a distribution or distributions on Common Shares or any other equity or equity equivalent securities payable in Common Shares (which,
for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this Warrant), (b) subdivides outstanding
Common Shares into a larger number of shares, (c) combines (including by way of reverse stock split) outstanding Common Shares into a
smaller number of shares, or (d) issues by reclassification of Common Shares any shares of capital stock of the Company, then in each
case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding treasury
shares, if any) outstanding immediately before such event and of which the denominator shall be the number of Common Shares outstanding
immediately after such event and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that
the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 5.1 shall become
effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and
shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

5.2
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of Common Shares, by way of return of capital or otherwise
(including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of Common Shares acquirable upon
complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of Common Shares are to be determined for the participation in such Distribution (provided, however,
that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the beneficial
ownership limitation provided for in Section 10, then the Holder shall not be entitled to participate in such Distribution to
such extent (or in the beneficial ownership of any Common Shares as a result of such Distribution to such extent) and the portion of
such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the beneficial ownership limitation).

 

    -4-

    

    

 

5.3
Fundamental Transaction. If, at any time while this Warrant is outstanding, (a) the Company effects any merger, arrangement, amalgamation
or consolidation of the Company with or into another Person, (b) the Company effects any sale of all or substantially all of its assets
in one or a series of related transactions, (c) any tender offer or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Shares are permitted to tender or exchange their shares for other securities, cash or property, or
(d) the Company effects any reclassification of the Common Shares or any compulsory share exchange pursuant to which the Common Shares
are effectively converted into or exchanged for other securities, cash or property (each, a “Fundamental Transaction”),
then, upon the closing of a Fundamental Transaction and payment of the exercise price therefore (including at the election of the Holder
by cashless exercise), the Holder shall receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, the number of Common Shares of the successor or acquiring corporation or of
the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”)
receivable as a result of such merger, consolidation or disposition of assets by a holder of the number of Common Shares for which this
Warrant is exercisable immediately prior to such event. For purposes of any such exercise, the determination of the Exercise Price shall
be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon exercise of this Warrant upon the closing of such Fundamental
Transaction. The foregoing notwithstanding, if the Company effects any reclassification of the Common Shares or any compulsory share
exchange, in each case, into another security of the Company, this Warrant shall remain outstanding and the Holder shall be entitled
to receive the Alternative Consideration upon any subsequent exercise of this Warrant and the payment of the exercise price therefor.
The terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or
surviving entity to comply with the provisions of this Section 5.3

 

5.4
Adjustment to Exercise Price Upon Issuance of Common Shares. In the event the Company shall at any time or from time to time after
the Closing Date (but whether before or after the Issue Date) issue or sell any additional Common Shares (“Additional Common
Shares”), other than (A) as provided in the Note (including subsections (i) through (iv) of Section 3.4(a) of the Note),
pursuant to any Equity Plan (including pursuant to Common Share Equivalents granted or issued under any Equity Plan), (B) pursuant to
Common Share Equivalents (as defined in the Note) granted or issued prior to the Closing Date, (C) Exempted Securities or (D) pursuant
to the terms of this Warrant or the Note, in any case, at an effective price per share that is less than the Exercise Price
then in effect or without consideration, then the Exercise Price upon each such issuance shall be reduced to a price equal to the consideration
per share paid for such Additional Common Shares. For purposes of clarification, the amount of consideration received for such Additional
Common Shares shall not include the value of any additional securities or other rights received in connection with such issuance of Additional
Common Shares (i.e., warrants, rights of first refusal or other similar rights).

 

5.5
Calculations. All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 5, the number of Common Shares deemed to be issued and outstanding as of a given
date shall be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding at the close of the Trading
Day on or, if not applicable, most recently preceding, such given date.

 

5.6
Notice to Holder.

 

(a)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 5, the
Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and setting forth a brief statement
of the facts requiring such adjustment.

 

    -5-

    

    

 

(b)
Notice to Allow Exercise by Holder. If (i) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Shares; (ii) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares; (iii)
the Company shall authorize the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights; (iv) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Shares, any consolidation or merger to which the Company is a party, any sale or transfer of
all or substantially all of the assets of the Company, of any compulsory share exchange whereby the Common Shares are converted into
other securities, cash or property; or (v) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company; then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall
appear upon the Warrant Register of the Company, at least twenty (20) calendar days prior to the applicable record or effective date
hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Shares of record shall be entitled to exchange their Common Shares for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to mail such
notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified
in such notice. Subject to applicable law, the Holder is entitled to exercise this Warrant during the period commencing on the date of
such notice to the effective date of the event triggering such notice. Notwithstanding the foregoing, the delivery of the notice described
in this Section 5.6 is not intended to and shall not bestow upon the Holder any voting rights whatsoever with respect to outstanding
unexercised Warrants.

 

6.
NO IMPAIRMENT. The Company will not, by amendment of the Articles of Incorporation or through any reorganization, transfer of
assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms
and in taking all such action as may be necessary or appropriate in order to protect the rights of the Holder against impairment. Without
limiting the generality of the foregoing, the Company (a) will not increase the par value of any Common Shares receivable on the exercise
of this Warrant above the amount payable therefor on such exercise and (b) will take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and non-assessable shares of stock on the exercise of this Warrant
from time to time outstanding.

 

7.
NOTICES OF RECORD DATE. In the event of:

 

(a)
any taking by the Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who
are entitled to receive any dividend or other distribution, or any right to subscribe for, purchase or otherwise acquire any shares of
stock of any class or any other securities or property, or to receive any other right;

 

(b)
any capital reorganization of the Company, any reclassification or recapitalization of the capital stock of the Company or any transfer
of all or substantially all the assets of the Company to or any consolidation or merger of the Company with or into any other Person
or any other Change of Control; or

 

(c)
any voluntary or involuntary dissolution, liquidation or winding-up of the Company;

 

then,
and in each such event, the Company will mail or cause to be mailed to the Holder a notice specifying (i) the date on which any such
record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend,
distribution or right, or (ii) the date on which any such reorganization, reclassification, recapitalization, transfer, consolidation,
merger, dissolution, liquidation or winding-up is anticipated to take place, and the time, if any is to be fixed, as of which the holders
of record of Common Shares shall be entitled to exchange their Common Shares for securities or other property deliverable on such reorganization,
reclassification, recapitalization, transfer, consolidation, merger, dissolution, liquidation or winding-up. Such notice shall be mailed
at least fifteen (15) days prior to the date specified in such notice on which any such action is to be taken.

 

    -6-

    

    

 

8.
RESERVATION OF STOCK ISSUABLE ON EXERCISE OF WARRANT; REGULATORY COMPLIANCE.

 

8.1.
Reservation of Stock Issuable on Exercise of Warrant. The Company shall at all times while this Warrant shall be outstanding,
reserve and keep available out of its authorized but unissued Common Shares, such number of Common Shares as shall from time to time
be sufficient to effect the exercise of all or any portion of the Warrant Shares (disregarding for this purpose any and all limitations
of any kind on such exercise). The Company shall, from time to time in accordance with the Business Corporations Act (British
Columbia), increase the authorized number of Common Shares or take other effective action if at any time the unissued number of authorized
shares shall not be sufficient to satisfy the Company’s obligations under this Section 8.

 

8.2.
Regulatory Compliance. If any Common Shares to be reserved for the purpose of exercise of the Warrant Shares require registration
or listing with or approval of any Governmental Authority, stock exchange or other regulatory body under any federal, provincial or state
law or regulation or otherwise before such shares may be validly issued or delivered upon exercise, the Company shall, at its sole cost
and expense, in good faith and as expeditiously as possible, secure such registration, listing or approval, as the case may be.

 

9.
DEFINITIONS. As used herein the following terms, unless the context otherwise requires, have the following respective meanings:

 

“Affiliate”
means a Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control
with, the Person specified.

 

“Aggregate
Exercise Price” means, in connection with the exercise of this Warrant at any time, an
amount equal to the product obtained by multiplying (i) the Exercise Price times (ii) the number of Common Shares for which this Warrant
is being exercised at such time.

 

“Articles
of Incorporation” means the Company’s notice of articles or articles, as amended to date.

 

“Business
Day” means any day other than a Saturday, Sunday or any other day on which banks are permitted or required to be closed in
New York City.

 

“Change
of Control” has the meaning set forth in the Purchase Agreement.

 

“Common
Shares” means (i) the Company’s Common Shares, no par value per share, and (ii) any other securities into which or for
which any of the securities described in clause (i) above have been converted or exchanged pursuant to a plan of recapitalization, reorganization,
merger, sale of assets or otherwise.

 

“Convertible
Securities” means any debt, equity or other securities that are, directly or indirectly, convertible into or exchangeable for
Common Shares.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder from time
to time in effect.

 

    -7-

    

    

 

“Exercise
Period” means the period commencing on the Issue Date and ending 11:59 P.M. (New York City time) on the date that is sixty
(60) months from the Issue Date or earlier closing of a Fundamental Transaction (other than a Fundamental Transaction of the type described
in clause (d) of the definition thereof resulting in the conversion into or exchange for another security of the Company).

 

“Exercise
Price” means $4.00 per share, as may be adjusted pursuant to the terms hereof.

 

“Exercise
Shares” means the Common Shares for which this Warrant is then being exercised.

 

“Fair
Market Value” means, with respect to any security or other property, the fair market value of such security or other property
as determined by the Board of Directors, acting in good faith.

 

“Governmental
Authority” means the government of the United States, Canada or any other nation, or of any political subdivision thereof,
whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive,
legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national
bodies such as the European Union or the European Central Bank).

 

“Issue
Date” means October 26, 2021.

 

“Note”
means the senior secured convertible promissory note issued by the Company to the Holder pursuant to the
Purchase Agreement.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint
venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder from time to time in
effect.

 

“Subsidiary”
means, as of any time of determination and with respect to any Person, any United States corporation, partnership, limited liability
company or limited liability partnership, all of the stock (or other equity interest) of every class of which, except directors’
qualifying shares (or any equivalent), shall, at such time, be owned by such Person either directly or through Subsidiaries and of which
such Person or a Subsidiary shall have 100% control thereof, except directors’ qualifying shares. Unless the context otherwise
clearly requires, any reference to a “Subsidiary” is a reference to a Subsidiary of the Company.

 

“Trading
Day” means a day on which the Common Shares are traded on a Trading Market.

 

“Trading
Market” means whichever of the New York Stock Exchange, NYSE: Amex Exchange, or the Nasdaq Stock Market (including the Nasdaq
Capital Market), on which the Common Shares are listed or quoted for trading on the date in question.

 

“VWAP”
means, as of any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then listed
or quoted on a Trading Market, the daily volume weighted average price of one Common Share trading in the ordinary course of business
on the applicable Trading Price for such date (or the nearest preceding date) on such Trading Market as reported by Bloomberg Financial
L.P.; (b) if the Common Shares are not then listed on a Trading Market and if the Common Shares are traded in the over-the-counter market,
as reported by the OTC Bulletin Board, the volume weighted average price of one Common Share for such date (or the nearest preceding
date) on the OTC Bulletin Board, as reported by Bloomberg Financial L.P.; (c) if the Common Shares are not then listed or quoted on the
OTC Bulletin Board and if prices for the Common Shares are then reported in the “Pink Sheets” published by the Pink OTC Markets
Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price of one Common Share
so reported, as reported by Bloomberg Financial L.P.; or (d) in all other cases, the fair market value of one Common Share as determined
by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company (in each case rounded to four
decimal places).

 

    -8-

    

    

 

“Warrant
Shares” means collectively the Common Shares of the Company issuable upon exercise of
the Warrant in accordance with its terms, as such number may be adjusted pursuant to the provisions thereof.

 

10.
LIMITATION ON BENEFICIAL OWNERSHIP. Notwithstanding anything to the contrary contained herein, the Holder shall not be entitled
to receive Common Shares or other securities (together with Common Shares, “Equity Interests”) upon exercise of this
Warrant to the extent (but only to the extent) that such exercise or receipt would cause the Holder Group to become, directly or indirectly,
a “beneficial owner” (within the meaning of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder)
of a number of Equity Interests of a class that is registered under the Exchange Act which exceeds the Maximum Percentage (as defined
below) of the Equity Interests of such class that are outstanding at such time. Any purported delivery of Equity Interests in connection
with the exercise of the Warrant prior to the termination of this restriction in accordance herewith shall be void and have no effect
to the extent (but only to the extent) that such delivery would result in the Holder Group becoming the beneficial owner of more than
the Maximum Percentage of the Equity Interests of a class that is registered under the Exchange Act that is outstanding at such time.
If any delivery of Equity Interests owed to the Holder following exercise of this Warrant is not made, in whole or in part, as a result
of this limitation, the Company’s obligation to make such delivery shall not be extinguished and the Company shall deliver such
Equity Interests as promptly as practicable after the Holder gives notice to the Company that such delivery would not result in such
limitation being triggered or upon termination of the restriction in accordance with the terms hereof. To the extent limitations contained
in this Section 10 apply, the determination of whether this Warrant is exercisable and of which portion of this Warrant is exercisable
shall be the sole responsibility and in the sole determination of the Holder, and the submission of an Exercise Notice shall be deemed
to constitute the Holder’s determination that the issuance of the full number of Warrant Shares requested in the Exercise Notice
is permitted hereunder, and neither the Company nor any Warrant agent shall have any obligation to verify or confirm the accuracy of
such determination. For purposes of this Section 10, (i) the term “Maximum Percentage” shall mean 4.99%; provided,
that if at any time after the date hereof the Holder Group beneficially owns in excess of 4.99% of any class of Equity Interests in the
Company that is registered under the Exchange Act (excluding any Equity Interests deemed beneficially owned by virtue of this Warrant
or the Note), then the Maximum Percentage shall automatically increase to 9.99% so long as the Holder Group owns in excess of 4.99% of
such class of Equity Interests (and shall, for the avoidance of doubt, automatically decrease to 4.99% upon the Holder Group ceasing
to own in excess of 4.99% of such class of Equity Interests); and (ii) the term “Holder Group” shall mean the Holder
plus any other Person with which the Holder is considered to be part of a group under Section 13 of the Exchange Act or with which the
Holder otherwise files reports under Sections 13 and/or 16 of the Exchange Act. In determining the number of Equity Interests of a particular
class outstanding at any point in time, the Holder may rely on the number of outstanding Equity Interests of such class as reflected
in (x) the Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the Securities and Exchange
Commission, as the case may be, (y) a more recent public announcement by the Company or (z) a more recent notice by the Company or its
transfer agent to the Holder setting forth the number of Equity Interests of such class then outstanding. For any reason at any time,
upon written or oral request of the Holder, the Company shall, within one (1) Trading Day of such request, confirm orally and in writing
to the Holder the number of Equity Interests of any class then outstanding. The provisions of this Section 10 shall be construed,
corrected and implemented in a manner so as to effectuate the intended beneficial ownership limitation herein contained.

 

    -9-

    

    

 

11.
REGISTRATION AND TRANSFER OF WARRANT.

 

11.1.
Registration of Warrant. The Company shall register and record transfers, exchanges, reissuances and cancellations of this Warrant,
upon the records to be maintained by the Company for that purpose, in the name of the record holder hereof from time to time. The Company
may deem and treat the registered holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary. The Company shall be entitled to rely, and held harmless
in acting or refraining from acting in reliance upon, any notices, instructions or documents it believes in good faith to be from an
authorized representative of the Holder.

 

11.2
Transferability. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form of assignment (the “Assignment Notice”) attached hereto duly
executed by the Holder or its agent or attorney. The Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the
effect that such transfer does not require registration of the transferred Warrant under the 1933 Act. Upon such surrender, the Company
shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such Assignment Notice, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant
not so assigned, and this Warrant shall promptly be cancelled. This Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Exercise Shares without having a new Warrant issued.

 

11.3.
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 11.2, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for this Warrant or Warrants to
be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue
Date and shall be identical with this Warrant except as to the number of Exercise Shares issuable pursuant thereto.

 

12.
LOSS, THEFT, DESTRUCTION OR MUTILATION OF WARRANT. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Exercise Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of this Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.

 

13.
REMEDIES. The Company stipulates that the remedies at law of the Holder in the event of any default or threatened default by the
Company in the performance of or compliance with any of the terms of this Warrant are not and will not be adequate, and that such terms
may be specifically enforced by a decree for the specific performance of any agreement contained herein or by an injunction against a
violation of any of the terms hereof or otherwise.

 

    -10-

    

    

 

14.
NO RIGHTS AS A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in such Person’s capacity
as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company
for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person’s capacity
as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any
corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise),
receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Exercise
Shares.

 

15.
NOTICES. All notices, requests, demands and other communications that are required or may be given pursuant to the terms of this
Warrant shall be in writing and shall be deemed delivered (i) on the date of delivery when delivered by hand on a Business Day during
normal business hours or, if delivered on a day that is not a Business Day or after normal business hours, then on the next Business
Day, (ii) on the date of transmission when sent by facsimile transmission or email during normal business hours on a Business Day with
telephone confirmation of receipt or, if transmitted on a day that is not a Business Day or after normal business hours, then on the
next Business Day, or (iii) on the second Business Day after the date of dispatch when sent by a reputable courier service that maintains
records of receipt. The addresses for notice shall be as set forth in the Purchase Agreement.

 

16.
CONSENT TO AMENDMENTS. Any term of this Warrant may be amended, and the Company may take any action herein prohibited, or compliance
therewith may be waived, only if the Company shall have obtained the written consent (and not without such written consent) to such amendment,
action or waiver from the Holder. No course of dealing between the Company and the Holder nor any delay in exercising any rights hereunder
shall operate as a waiver of any rights of the Holder.

 

17.
MISCELLANEOUS. In case any provision of this Warrant shall be invalid, illegal or unenforceable, or partially invalid, illegal
or unenforceable, the provision shall be enforced to the extent, if any, that it may legally be enforced and the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or impaired thereby. If any provision of this Warrant is
found to conflict with the Purchase Agreement, the provisions of this Warrant shall prevail. If any provision of this Warrant is found
to conflict with the Note, the provisions of the Note shall prevail. THIS WARRANT SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH,
AND THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE INTERNAL LAW OF THE STATE OF NEW YORK EXCLUDING CHOICE-OF-LAW PRINCIPLES OF THE
LAW OF SUCH STATE THAT WOULD PERMIT THE APPLICATION OF THE LAWS OF A JURISDICTION OTHER THAN SUCH STATE. The headings in this Warrant
are for purposes of reference only, and shall not limit or otherwise affect any of the terms hereof.

 

[Remainder
of Page Intentionally Left Blank]

 

    -11-

    

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its duly authorized officer.

 

Dated
as of October 26, 2021

 

	 	siyata mobile
    inc.
	 	 
	 	By:	    
	 	Name:	Marc Seelenfreund
	 	Title: 	Chief Executive Officer

 

    -12-

    

    

 

FORM
OF SUBSCRIPTION

 

(To
be signed only on exercise

of
Common Shares Purchase Warrant)

 

		TO:	Siyata
                                            Mobile Inc.

 

1.
The undersigned Holder of the attached Warrant hereby elects to exercise its purchase right under such Warrant to purchase Common Shares
of Siyata Mobile Inc., a British Columbia corporation (the “Company”), as follows (check one or more, as applicable):

 

		☐	to
                                            exercise the Warrant to purchase __________ Common Shares and to pay the Aggregate Exercise
                                            Price therefor by wire transfer of United States funds to the account of the Company, which
                                            transfer has been made prior to or as of the date of delivery of this Form of Subscription
                                            pursuant to the instructions of the Company;

 

and/or

 

		☐	to
                                            exercise the Warrant with respect to ____________ Common Shares pursuant to the net exercise
                                            provisions specified in Section 2.3 of the Warrant.

 

2.
In exercising this Warrant, the undersigned Holder hereby confirms and acknowledges that the Common Shares are being acquired solely
for the account of the undersigned and not as a nominee for any other party, and for investment, and that the undersigned shall not offer,
sell or otherwise dispose of any such Common Shares except under circumstances that will not result in a violation of the Securities
Act or any state securities laws. The undersigned hereby further confirms and acknowledges that it is an “accredited investor”,
as that term is defined under the Securities Act.

 

3.
Please issue a stock certificate or certificates representing the appropriate number of Common Shares in the name of the undersigned
or in such other name(s) as is specified below:

 

Name:                                                                                      

 

Address:                                                                                  

 

                                                                                  

 

                                                                                  

 

                                                                                  

 

TIN:                                                                                       

 

	                                                                                           

    (Signature
    must conform exactly to name of Holder as specified on the face of the Warrant)
	 	

    Dated:
                                                        

 

     

    

    

 

FORM
OF ASSIGNMENT

(To
be signed only on transfer of Warrant)

 

For
value received, the undersigned hereby sells, assigns, and transfers unto ________________ the right represented by the within Warrant
to purchase        Common Shares of Siyata Mobile Inc., a British Columbia corporation, to which the within
Warrant relates, and appoints _________________ attorney to transfer such right on the books of Siyata Mobile Inc., with full power of
substitution in the premises.

 

	 	[insert name of Holder]
	 	 	 
	Dated: _____________________	By:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	[insert address of Holder]

 

Signed
in the presence of:

 

________________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]